BLOOD

BLOOD

BLOOD
影响因子:23.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:American Society of Hematology
发刊时间:1946
发刊频率:Semimonthly
收录数据库:SCIE/Scopus收录
ISSN:0006-4971

期刊介绍

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.
Blood是美国血液学学会的官方期刊,在线和印刷出版,为发表描述血液学基础实验室、转化和临床研究的原创文章提供了一个国际论坛。手稿的接受是基于观察或调查的原创性和重要性,工作的质量和证据的有效性,陈述的清晰度,以及与我们的读者群和领域的相关性。所有的文章都应该是简洁的,组织良好的,写得清楚。作者提交手稿时,应了解该手稿(或其基本内容)除作为摘要以任何语言或格式发表外,尚未以其他形式发表,且目前尚未提交印刷或电子出版物。主要研究文章将按以下科学类别发表:临床试验和观察;基因治疗;造血与干细胞;免疫生物学和免疫治疗范围;髓系肿瘤;淋巴瘤;吞噬细胞、粒细胞与骨髓细胞生成血小板与血小板生成;红细胞、铁与红细胞生成血栓形成和止血;输血医学;移植;和血管生物学。论文可根据需要列在多个类别下。如果作者不确定自己的工作是否福尔斯期刊的一般范围,请在投稿前与主编联系。
年发文量 435
国人发稿量 31.45
国人发文占比 0.07%
自引率 -
平均录取率0
平均审稿周期 平均1.0个月
版面费 US$2500
偏重研究方向 医学-血液学
期刊官网 http://bloodjournal.hematologylibrary.org/
投稿链接 http://submit.bloodjournal.org/

期刊高被引文献

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
来源期刊:BloodDOI:10.1182/blood-2019-01-894980
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.
来源期刊:BloodDOI:10.1182/blood-2018-09-876805
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.
来源期刊:BloodDOI:10.1182/blood-2018-09-876136
Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3.
来源期刊:BloodDOI:10.1182/blood-2018-09-873984
Mechanisms of immune escape after allogeneic hematopoietic cell transplantation.
来源期刊:BloodDOI:10.1182/blood-2018-10-846824
Neutrophils: back in the thrombosis spotlight.
来源期刊:BloodDOI:10.1182/blood-2018-10-862243
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1.
来源期刊:BloodDOI:10.1182/blood-2018-07-865378
A Niche-Dependent Myeloid Transcriptome Signature Defines Dormant Myeloma Cells.
来源期刊:BloodDOI:10.1182/blood.2018880930
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T cell cytotoxicity.
来源期刊:BloodDOI:10.1182/blood.2019002121
CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX knockout mice.
来源期刊:BloodDOI:10.1182/blood.2019000790
EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.
来源期刊:BloodDOI:10.1182/blood.2018893404
Neutrophil transendothelial migration: updates and new perspectives.
来源期刊:BloodDOI:10.1182/blood-2018-12-844605
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
来源期刊:BloodDOI:10.1182/blood-2018-06-856062
Peripheral serotonin causes dengue virus-induced thrombocytopenia through 5HT2 receptors.
来源期刊:BloodDOI:10.1182/blood-2018-08-869156
The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia.
来源期刊:BloodDOI:10.1182/blood.2018874503
PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia.
来源期刊:BloodDOI:10.1182/blood-2018-07-860726
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR.
来源期刊:BloodDOI:10.1182/blood-2018-06-860015
Cross talk between neutrophils and the microbiota.
来源期刊:BloodDOI:10.1182/blood-2018-11-844555
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary Syndrome.
来源期刊:BloodDOI:10.1182/blood.2019000765
Low-dose chidamide restores immune tolerance in ITP in mice and humans.
来源期刊:BloodDOI:10.1182/blood-2018-05-847624
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.
来源期刊:BloodDOI:10.1182/blood-2018-10-878892
Epo receptor marks the spot.
来源期刊:BloodDOI:10.1182/blood.2019001581
Cannibalistic acute myeloid leukemia with ZMYND11-MBTD1 fusion.
来源期刊:BloodDOI:10.1182/blood-2019-01-898619
MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.
来源期刊:BloodDOI:10.1182/blood-2018-11-885467
Rivaroxaban for Treatment of Pediatric Venous Thromboembolism. an Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation
来源期刊:BloodDOI:10.1182/blood-2019-124873
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients.
来源期刊:BloodDOI:10.1182/blood.2019000420
CAR-T-cell neurotoxicity: hope is on the horizon.
来源期刊:BloodDOI:10.1182/blood-2019-03-900985
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma.
来源期刊:BloodDOI:10.1182/blood.2019001866
Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
来源期刊:BloodDOI:10.1182/blood-2018-03-837344
Proteomics evidence of specific IGKV1-8 association with cystic lung light chain deposition disease.
来源期刊:BloodDOI:10.1182/blood.2019898577
Closing the loop on cohesin in hematopoiesis.
来源期刊:BloodDOI:10.1182/blood.2019003279
Intraocular toxoplasmosis mimicking vitreous lymphoma.
来源期刊:BloodDOI:10.1182/blood-2018-10-883124
Introduction to a review series on human neutrophils.
来源期刊:BloodDOI:10.1182/blood-2019-01-891770
PTPRJ: a novel inherited thrombocytopenia gene.
来源期刊:BloodDOI:10.1182/blood-2019-01-895102
Development of a virtual benign hematology consultation service: results of a pilot project involving 5 medical centers.
来源期刊:BloodDOI:10.1182/blood-2018-11-887349
TP53 Deficient/Mutant AMLs Are Resistant to Individual BH3 Mimetics: High Efficacy of Combined Inhibition of Bcl-2 and Mcl-1
来源期刊:BloodDOI:10.1182/blood-2019-124826
Ponatinib and platelets a conflict in CML.
来源期刊:BloodDOI:10.1182/blood-2019-02-900472
More than one pathway: novel treatment for ITP.
来源期刊:BloodDOI:10.1182/blood-2018-12-892778
Biphenotypic plasma cell myeloma.
来源期刊:BloodDOI:10.1182/blood-2019-01-898171
Illuminating neutrophilic myeloid neoplasms.
来源期刊:BloodDOI:10.1182/blood.2019002302
Running the tank to empty: how far can the CAR go?
来源期刊:BloodDOI:10.1182/blood-2019-02-900761
HAP1 loss in l-asparaginase resistance.
来源期刊:BloodDOI:10.1182/blood-2019-03-900993
A unique genome in EBV-positive BL.
来源期刊:BloodDOI:10.1182/blood-2019-01-897603
Lymphocytes in Sanfilippo syndrome display characteristic Alder-Reilly anomaly.
来源期刊:BloodDOI:10.1182/blood.2019002412
Hepatocyte tPA: where have you been hiding?
来源期刊:BloodDOI:10.1182/blood-2018-12-891515
APC ameliorates pulmonary complications in cGVHD.
来源期刊:BloodDOI:10.1182/blood.2019002182
RAGs usurp cellular factors for both breaking and repairing.
来源期刊:BloodDOI:10.1182/blood-2019-01-892729
A new medical therapy for anemia in thalassemia.
来源期刊:BloodDOI:10.1182/blood-2019-01-897587
In ALD, I feel the need for speed.
来源期刊:BloodDOI:10.1182/blood-2019-02-897629
Megakaryocytes from fat: a new recipe for platelets.
来源期刊:BloodDOI:10.1182/blood-2018-12-889766

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
85.98%35.93%-5.45%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
HEMATOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学1区
HEMATOLOGY 血液学
1区
2023年12月升级版
医学1区
HEMATOLOGY 血液学
1区
2022年12月旧的升级版
医学1区
HEMATOLOGY 血液学
1区